Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characteristics of Opioid Toxicity Deaths Among Adolescents and Young Adults in Ontario Prior To and During the COVID-19 Pandemic.
Akbar S, Iacono A, Yang J, Antoniou T, Juurlink D, Sheikh H, Kurdyak P, Wu F, Cheng C, Leece P, Kolla G, Emblem J, Shearer D, Gomes T. Akbar S, et al. Among authors: leece p. J Adolesc Health. 2024 Apr 9:S1054-139X(24)00114-9. doi: 10.1016/j.jadohealth.2024.02.024. Online ahead of print. J Adolesc Health. 2024. PMID: 38597841 Free article.
Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada.
Greenwald ZR, Werb D, Feld JJ, Austin PC, Fridman D, Bayoumi AM, Gomes T, Kendall CE, Lapointe-Shaw L, Scheim AI, Bartlett SR, Benchimol EI, Bouck Z, Boucher LM, Greenaway C, Janjua NZ, Leece P, Wong WWL, Sander B, Kwong JC. Greenwald ZR, et al. Among authors: leece p. J Clin Epidemiol. 2024 Mar 24;170:111332. doi: 10.1016/j.jclinepi.2024.111332. Online ahead of print. J Clin Epidemiol. 2024. PMID: 38522754 Free article.
Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada.
Iacono A, Wang T, Tadrous M, Campbell T, Kolla G, Leece P, Sproule B, Kleinman RA, Besharah J, Munro C, Doolittle M, Gomes T. Iacono A, et al. Among authors: leece p. Drug Alcohol Depend. 2024 Jan 1;254:111032. doi: 10.1016/j.drugalcdep.2023.111032. Epub 2023 Nov 19. Drug Alcohol Depend. 2024. PMID: 38043224 Free article.
Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use.
Corace K, Thavorn K, Suschinsky K, Willows M, Leece P, Kahan M, Nijmeh L, Aubin N, Roach M, Garner G, Saskin R, Kim E, Rice D, Taha S, Garber G, Hutton B. Corace K, et al. Among authors: leece p. JAMA Netw Open. 2023 Nov 1;6(11):e2344528. doi: 10.1001/jamanetworkopen.2023.44528. JAMA Netw Open. 2023. PMID: 37991762 Free PMC article.
Document d’orientation sur la distribution et l’utilisation de trousses de naloxone à emporter par les intervenants et intervenantes communautaires en cas de surdose au Canada.
Ferguson M, Rittenbach K, Leece P, Adams A, Ali F, Elton-Marshall T, Burmeister C, Brothers TD, Medley A, Choisil P, Strike C, Ng J, Lorenzetti DL, Gallant K, Buxton JA; le groupe d’élaboration des documents d’orientation relative à la naloxone pour. Ferguson M, et al. Among authors: leece p. CMAJ. 2023 Oct 3;195(38):E1312-E1325. doi: 10.1503/cmaj.230128-f. CMAJ. 2023. PMID: 37788838 Free PMC article. French.
Guidance on take-home naloxone distribution and use by community overdose responders in Canada.
Ferguson M, Rittenbach K, Leece P, Adams A, Ali F, Elton-Marshall T, Burmeister C, Brothers TD, Medley A, Choisil P, Strike C, Ng J, Lorenzetti DL, Gallant K, Buxton JA; Naloxone Guidance Development Group. Ferguson M, et al. Among authors: leece p. CMAJ. 2023 Aug 28;195(33):E1112-E1123. doi: 10.1503/cmaj.230128. CMAJ. 2023. PMID: 37640401 Free PMC article.
79 results